Confusable diagnoses · PANCE / PANRE

Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome

Heparin-Induced Thrombocytopenia and Antiphospholipid Syndrome are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.

Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome at a glance

  • Heparin-Induced Thrombocytopenia: Antibody-mediated platelet activation by heparin-PF4 complexes causing paradoxical thrombosis with thrombocytopenia.
  • Antiphospholipid Syndrome: Autoimmune disorder with antiphospholipid antibodies causing arterial/venous thrombosis and pregnancy morbidity.

Try two board-style questions on Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1HematologyMedium
A 69-year-old man has a platelet count fall from 240,000/µL to 85,000/µL five days after cardiac surgery requiring bypass. He develops a painful swollen leg. Which of the following is the strongest risk factor for this syndrome?
  • AUse of low-molecular-weight heparin
  • BUse of fondaparinux for prophylaxis
  • CUse of unfractionated heparin
  • DUse of warfarin for prophylaxis
Reveal answer & full explanation
Correct answer: C — Use of unfractionated heparin
  • AUse of low-molecular-weight heparin
  • BUse of fondaparinux for prophylaxis
  • CUse of unfractionated heparin✓
  • DUse of warfarin for prophylaxis

Why Use of unfractionated heparin is correct

  • Heparin-induced thrombocytopenia is driven by antibodies to platelet factor 4-heparin complexes, and unfractionated heparin binds PF4 far more avidly than other agents, giving it the highest HIT risk.
  • The post-cardiac-surgery setting compounds risk, as bypass exposes patients to high-dose UFH and the highest PF4 antibody seroconversion rates.
  • A 50% platelet drop at day 5 with new limb thrombosis is the classic timing and thrombotic phenotype of HIT.

Why the others are wrong

  • Use of low-molecular-weight heparin — Right-drug-class wrong-magnitude trap: LMWH can cause HIT but at roughly one-tenth the rate of UFH, so it is not the strongest risk factor.
  • Use of fondaparinux for prophylaxis — Buzzword-reversal trap: fondaparinux essentially does not form immunogenic PF4 complexes and is actually used to treat HIT, not cause it.
  • Use of warfarin for prophylaxis — Anchoring trap: warfarin causes no PF4 immune reaction, and starting it during acute HIT risks warfarin-induced limb gangrene.
Question 2HematologyMedium
A 38-year-old woman presents with recurrent deep vein thromboses (DVTs) and a spontaneous miscarriage at 14 weeks. She has livedo reticularis on exam. Labs show prolonged PTT that does not correct with mixing study. Anti-cardiolipin IgG and lupus anticoagulant are positive on two separate occasions 12 weeks apart. What is the most likely diagnosis?
  • AHeparin-induced thrombocytopenia
  • BFactor V Leiden
  • CAntiphospholipid syndrome
  • DProtein C deficiency
Reveal answer & full explanation
Correct answer: C — Antiphospholipid syndrome
  • AHeparin-induced thrombocytopenia
  • BFactor V Leiden
  • CAntiphospholipid syndrome✓
  • DProtein C deficiency

Why Antiphospholipid syndrome is correct

  • Antiphospholipid syndrome (APS) requires clinical criteria (thrombosis or pregnancy morbidity) plus lab criteria (positive antiphospholipid antibodies on two occasions 12 weeks apart: lupus anticoagulant, anti-cardiolipin IgG/IgM, or anti-beta2-glycoprotein-I)
  • This patient meets both: recurrent DVTs and spontaneous miscarriage at 14 weeks (clinical); positive anti-cardiolipin IgG and lupus anticoagulant on two separate occasions 12 weeks apart (lab)
  • Prolonged PTT that does not correct with mixing (inhibitor pattern) is characteristic of lupus anticoagulant

Why the others are wrong

  • Heparin-induced thrombocytopenia — HIT causes thrombocytopenia and thrombosis but requires prior heparin exposure; no heparin exposure is mentioned, and it does not explain the positive antiphospholipid antibodies or prolonged PTT inhibitor pattern
  • Factor V Leiden — causes thrombophilia but does not explain prolonged PTT with inhibitor pattern, positive antiphospholipid antibodies, or pregnancy loss in this pattern
  • Protein C deficiency — causes thrombophilia but would not cause a prolonged PTT that fails to correct with mixing, nor positive antiphospholipid antibodies

Additional high-yield points

  • Treatment: warfarin (target INR 2-3 for venous thrombosis; INR 3-4 for recurrent or arterial thrombosis)
  • Direct oral anticoagulants (DOACs) are not preferred in APS — rivaroxaban was inferior to warfarin (more thrombotic events) in triple-positive APS in the TRAPS trial
🔒 Free preview limit reached

Keep comparing — start your free trial

You've used your 2 free previews. Create your free account to see the full Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.

Free to start · No credit card · Cancel anytime

Side-by-side comparison

FeatureHeparin-Induced ThrombocytopeniaAntiphospholipid Syndrome
At a glanceAntibody-mediated platelet activation by heparin-PF4 complexes causing paradoxical thrombosis with thrombocytopenia.Autoimmune disorder with antiphospholipid antibodies causing arterial/venous thrombosis and pregnancy morbidity.
Classic presentationPlatelet count fall 5-10 days after starting heparin with new thrombosis — the 'paradoxical' picture of thrombocytopenia with clotting rather than bleeding.; Often asymptomatic platelet drop noticed on routine CBC 5-10 days after starting heparin; Rapid-onset HIT (within hours) in patients with heparin exposure within prior 100 days;…Young patient with unprovoked venous or arterial thrombosis (DVT, PE, stroke) and/or recurrent pregnancy loss, often with livedo reticularis, mild thrombocytopenia, and a prolonged aPTT that does not correct on mixing study; antiphospholipid antibodies persist on repeat testing ≥12 weeks apart. Catastrophic APS is the rare variant:…
Workup / key labs4Ts score 0-3 (low) → HIT unlikely; 4-5 (intermediate) and 6-8 (high) → stop heparin, start non-heparin anticoagulant, send PF4 ELISA and confirmatory functional assay. Diagnosis = clinical probability + positive functional assay.; Calculate 4Ts score: Thrombocytopenia, Timing, Thrombosis, oTher causes (each 0-2 points);…Revised Sapporo (Sydney) criteria — requires ≥1 clinical criterion (vascular thrombosis or pregnancy morbidity) AND ≥1 laboratory criterion (LA, anti-cardiolipin, or anti-β2GP1) on two occasions at least 12 weeks apart. The 2023 ACR/EULAR classification criteria require an entry criterion (a positive aPL test within 3 years of an…
ImagingLower extremity venous duplex Doppler in all patients diagnosed with HIT; CT/CTA or other vascular imaging guided by clinical signs of thrombosis; CT abdomen if adrenal hemorrhage suspectedDuplex US, CTPA, MRI brain as clinically indicated by symptoms; Echocardiogram to evaluate for Libman-Sacks endocarditis
First-line treatmentSTOP all heparin immediately (including flushes, LMWH, heparin-coated catheters); Start non-heparin anticoagulant at therapeutic dose — argatroban (direct thrombin inhibitor, hepatic clearance) or bivalirudin (DTI, predominantly enzymatic/proteolytic clearance with minor renal component) for inpatients; fondaparinux or a DOAC is an…Acute thrombosis — therapeutic anticoagulation: unfractionated heparin or LMWH bridge to warfarin (INR 2-3); Long-term venous thrombosis — warfarin INR 2-3 indefinitely; Long-term arterial thrombosis or recurrent venous thrombosis on warfarin — warfarin INR 3-4, or warfarin + low-dose aspirin; DOACs (rivaroxaban, apixaban) are INFERIOR…

Drill Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome questions on FirstPassPA

Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.